NAT1
NAT1 (N-acetyltransferase 1, also known as arylamine N-acetyltransferase 1 or AAC1) is a cytoplasmic xenobiotic-metabolising enzyme. It transfers an acetyl group from acetyl-coenzyme A to arylamine and hydrazine substrates, contributing to the processing of drugs and carcinogens. Browse Assay Genie's current range of NAT1 research reagents below, or read on for the biology behind the target.
NAT1 is a xenobiotic-metabolising enzyme that catalyses both N-acetylation, which is usually a detoxification step, and O-acetylation, which is usually a bioactivation step. Its substrates are wide-ranging and species-specific, and include hydrazines, aromatic amine drugs and aromatic amine carcinogens. The enzyme transfers an acetyl group from acetyl-coenzyme A to arylamine and N-hydroxyarylamine acceptors. It can also move an N-acetyl group from an N-hydroxy acetylamine to an N-hydroxyarylamine or arylamine when acetyl-coenzyme A is absent.
This dual chemistry explains the enzyme's importance in toxicology. By acting on N-hydroxyarylamines, NAT1 produces unstable acetoxy intermediates. These decompose to electrophiles that bind DNA, which can lead to mutagenesis and carcinogenesis. NAT1 therefore plays a significant role in both the bioactivation and the detoxification of many drugs and carcinogens. The NCBI Gene summary adds that the enzyme helps metabolise drugs and other xenobiotics and functions in folate catabolism.
The NAT1 gene is one of two arylamine N-acetyltransferase genes in the human genome, the other being NAT2. The summary notes that the human gene is orthologous to the mouse and rat Nat2 genes, and that multiple transcript variants encode different isoforms. The protein is cytoplasmic and belongs to the arylamine N-acetyltransferase family, which HGNC lists as the gene group Arylamine N-acetyltransferases. The approved name was previously N-acetyltransferase 1 (arylamine N-acetyltransferase), and AAC1 is a recorded alias.
NAT1 acetylates aromatic amine drugs and hydrazines, so it is a relevant enzyme for studying how xenobiotics are metabolised.
By activating N-hydroxyarylamines to reactive intermediates that bind DNA, NAT1 links xenobiotic metabolism to mutagenesis and carcinogenesis.
N-acetylation is usually a detoxification route, making NAT1 a focus for work on how aromatic amines are cleared.
The NCBI Gene summary assigns NAT1 a function in folate catabolism, connecting it to wider metabolic research.
NAT1 transfers an acetyl group from acetyl-coenzyme A to arylamine and N-hydroxyarylamine substrates. It carries out N-acetylation, usually detoxifying, and O-acetylation, usually bioactivating. It also helps metabolise drugs and other xenobiotics and functions in folate catabolism.
NAT1 is the HGNC symbol for N-acetyltransferase 1, also called arylamine N-acetyltransferase 1. AAC1 is a recorded alias. NCBI reports that multiple transcript variants of the gene encode different isoforms.
NAT1 and NAT2 are the two arylamine N-acetyltransferase genes in the human genome. According to NCBI, the human NAT1 gene is orthologous to the mouse and rat Nat2 genes. Check the datasheet of any product for its validated reactivity.
NAT2, the other human arylamine N-acetyltransferase, and further N-acetyltransferase family targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P18440; product specifications from Assay Genie datasheets.